The Role of D-Dimers in the Initial Evaluation of COVID-19.

COVID-19 D-dimer aspartate transaminase total bilirubin unfavorable evolution marker

Journal

Therapeutics and clinical risk management
ISSN: 1176-6336
Titre abrégé: Ther Clin Risk Manag
Pays: New Zealand
ID NLM: 101253281

Informations de publication

Date de publication:
2022
Historique:
received: 18 01 2022
accepted: 08 03 2022
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 8 4 2022
Statut: epublish

Résumé

The COVID-19 pandemic was noted for the high degree of contagion and the large number of cases, as well as for the various clinical forms, from asymptomatic towards rapid evolution to death. The hospitals limited care capacity imposed the need to identify some markers of unfavorable evolution. The purpose of our study is to identify the parameters correlated with COVID-19 unfavorable evolution and to draw the profile of the patient at risk of unfavorable evolution. This set of parameters will help the doctor in deciding whether to hospitalize a patient and in choosing the treatment. We performed a prospective, observational, actively controlled study on 849 patients with COVID-19, hospitalized in the Second Clinic of "Sf. Cuv. Parascheva" Infectious Diseases Clinical Hospital Galati, Romania, between 1.03.2020-30.11.2020. The parameters statistically significant modified at the admission of the patients with COVID-19 unfavorable evolution were age, oxygen saturation, D-dimers, creatine kinase (CK), troponin, erythrocytes sedimentation rate (ESR), leukocytes, lymphocytes, neutrophils, platelets, hemoglobin (Hb), aspartate transaminase (AST), total and direct bilirubin (TBIL, DBIL), urea, creatinine, serum glucose. Strong correlations were observed between the unfavorable evolution and the admission values of D-dimers, AST, TBIL and between D-dimers and AST, which suggests that D-dimers levels can be considered predictive for the alteration of liver function and for the negative prognosis of the patient. Coagulation disorders and acute respiratory failure are the prevailing causes of death from COVID-19. Together with other parameters that constitute the risk profile for severe COVID-19 evolution, the D-dimers dosing at admission proved to be extremely useful in the management of COVID-19.

Identifiants

pubmed: 35386179
doi: 10.2147/TCRM.S357214
pii: 357214
pmc: PMC8979569
doi:

Types de publication

Journal Article

Langues

eng

Pagination

323-335

Informations de copyright

© 2022 Baroiu et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Nano Today. 2021 Jun;38:101142
pubmed: 33815564
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Gastroenterology. 2020 Aug;159(2):765-767.e2
pubmed: 32333911
Int J Lab Hematol. 2021 Feb;43(1):110-115
pubmed: 32931146
J Hepatol. 2020 Sep;73(3):566-574
pubmed: 32298767
Clin Cosmet Investig Dermatol. 2021 Apr 30;14:419-423
pubmed: 33958887
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
Dermatol Ther. 2020 Nov;33(6):e14181
pubmed: 32794366
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Am J Emerg Med. 2020 Nov;38(11):2444-2454
pubmed: 33039218
Hepatology. 2020 Jul;72(1):287-304
pubmed: 32298473
Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 28;41(0):E006
pubmed: 32220276
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Liver Transpl. 2020 Jun;26(6):832-834
pubmed: 32196933
J Am Acad Dermatol. 2020 Aug;83(2):700
pubmed: 32283229
World J Gastroenterol. 2020 May 21;26(19):2323-2332
pubmed: 32476796
Ann Intern Med. 2020 Aug 18;173(4):268-277
pubmed: 32374815
Clin Cosmet Investig Dermatol. 2021 Feb 26;14:185-186
pubmed: 33664583
Hepatology. 2020 Sep;72(3):807-817
pubmed: 32473607
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
World J Clin Cases. 2021 Jun 6;9(16):3814-3825
pubmed: 34141738
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2539-2547
pubmed: 32840379
Medicina (Kaunas). 2021 May 13;57(5):
pubmed: 34068430
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2378-2379.e1
pubmed: 32497637
Aliment Pharmacol Ther. 2020 Aug;52(4):584-599
pubmed: 32638436
ERJ Open Res. 2020 Jul 13;6(2):
pubmed: 32685436
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Sens Int. 2021;2:100098
pubmed: 34766055

Auteurs

Liliana Baroiu (L)

Clinical Medical Department, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, Galati, Romania.

Ana Cristina Lese (AC)

"George Enescu" National University of Arts, Faculty of Visual Arts and Design, Iasi, Romania.

Ioana Anca Stefanopol (IA)

Departament of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, Galati, Romania.

Alina Iancu (A)

Departament of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, Galati, Romania.
Multidisciplinary Integrated Center of Dermatological Interface Research Center (MICDIR), "Dunărea de Jos" University of Galați, Galati, Romania.

Caterina Dumitru (C)

Multidisciplinary Integrated Center of Dermatological Interface Research Center (MICDIR), "Dunărea de Jos" University of Galați, Galati, Romania.
Pharmaceutical Sciences Department, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, Galati, Romania.

Alexandru Bogdan Ciubara (AB)

Departament of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, Galati, Romania.

Florin Ciprian Bujoreanu (FC)

Dermatology Department, "Sf. Parascheva" Infectious Diseases Clinical Hospital, Galati, Romania.

Nicusor Baroiu (N)

Manufacturing Engineering Department, Faculty of Engineering, "Dunărea de Jos" University of Galati, Galati, Romania.

Anamaria Ciubara (A)

Clinical Medical Department, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, Galati, Romania.

Alexandru Nechifor (A)

Clinical Medical Department, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, Galati, Romania.
Multidisciplinary Integrated Center of Dermatological Interface Research Center (MICDIR), "Dunărea de Jos" University of Galați, Galati, Romania.

Lucretia Anghel (L)

Clinical Medical Department, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, Galati, Romania.

Alin Laurentiu Tatu (AL)

Clinical Medical Department, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, Galati, Romania.
Multidisciplinary Integrated Center of Dermatological Interface Research Center (MICDIR), "Dunărea de Jos" University of Galați, Galati, Romania.
Dermatology Department, "Sf. Parascheva" Infectious Diseases Clinical Hospital, Galati, Romania.

Classifications MeSH